Cepheid
Charles Mwangi serves as the Senior Vice President and Chief Financial Officer at Cepheid since July 2023, following a brief sabbatical earlier in the year. Previous experience includes roles as Chief Financial Officer at Freenome and Senior Vice President and CFO of the Flash Division at Western Digital. Charles's career also encompasses senior financial leadership positions at Cepheid, Lam Research, Diageo, Avago Technologies, Affymetrix Inc, and Cisco Systems, demonstrating expertise in financial management, operational strategy, and corporate performance. Educational qualifications include a Master's in Applied Economics & Statistics from California State University - East Bay, an MBA in Finance from Alliant International University, and professional certifications such as CMA and FCCA.
This person is not in any teams
This person is not in any offices
Cepheid
9 followers
Cepheid is a molecular diagnostics company. The Company develops, manufactures and markets fully-integrated systems for testing in the Clinical and Non-Clinical markets. The Company's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The Company's systems integrate these steps and analyze biological samples in test cartridges. Its primary offering is the GeneXpert system, which integrates sample preparation in addition to Deoxyribonucleic acid (DNA) amplification and detection. The GeneXpert system is designed for a range of user types ranging from reference laboratories and hospital central laboratories to satellite testing locations, such as emergency departments and intensive care units within hospitals, as well as physician offices and other alternate site laboratories. It also offers the SmartCycler system, which integrates DNA amplification and detection to allow rapid analysis of a sample.